Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma
Oncotarget
.
2019 Sep 10;10(52):5494.
doi: 10.18632/oncotarget.27199.
Authors
Akihiro Ohmoto
1
,
Masami Suzuki
1
,
Erina Takai
1
,
Hirofumi Rokutan
2
,
Yuko Fujiwara
1
,
Chigusa Morizane
3
,
Kazuyoshi Yanagihara
4
,
Tatsuhiro Shibata
2
5
,
Shinichi Yachida
1
6
Affiliations
1
Laboratory of Clinical Genomics, National Cancer Center Research Institute, Tokyo, Japan.
2
Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo, Japan.
3
Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
4
Division of Biomarker Discovery, Exploratory Oncology and Clinical Trial Center, National Cancer Center, Chiba, Japan.
5
Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
6
Department of Cancer Genome Informatics, Graduate School of Medicine/Faculty of Medicine, Osaka University, Osaka, Japan.
PMID:
31534635
PMCID:
PMC6739219
DOI:
10.18632/oncotarget.27199
Abstract
[This corrects the article DOI: 10.18632/oncotarget.24930.].
Publication types
Published Erratum